Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
21 hedge funds and large institutions have $6.53M invested in Chembio diagnostics, Inc. in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
9% less funds holding
Funds holding: 23 → 21 (-2)
28% less capital invested
Capital invested by funds: $9.05M → $6.53M (-$2.52M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RVPG
Relative Value Partners Group
|
+$63.3K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$46.1K |
| 3 |
Morgan Stanley
New York
|
+$27.1K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$638K |
| 2 |
SLG
Stanley-Laman Group
Berwyn,
Pennsylvania
|
-$423K |
| 3 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$106K |
| 4 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$32K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$20.7K |
CEMI Hedge Fund Activity: Q3 2015 in Review
21 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q3 2015, worth a combined $6.53M — down 28% from $9.05M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CEMI and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 4 added.
The largest buyer was Relative Value Partners Group, opening a new position worth an estimated $63.3K. The largest seller was Acuta Capital Partners, exiting entirely with an estimated $638K sold.
- 21 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q3 2015, down from 23 in Q2 2015.
- Funds reported $6.53M of Chembio diagnostics, Inc. stock for Q3 2015, down 28% quarter-over-quarter.
- 2 funds opened new Chembio diagnostics, Inc. positions in Q3 2015 and 4 closed out, a net change of -2 holders.
- The largest Chembio diagnostics, Inc. buyer in Q3 2015 was Relative Value Partners Group, an estimated $63.3K added.
- The largest Chembio diagnostics, Inc. seller in Q3 2015 was Acuta Capital Partners, an estimated $638K sold.
Based on aggregated 13F filings for Q3 2015.